People: Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

12.60USD
19 Sep 2014
Price Change (% chg)

$-0.25 (-1.95%)
Prev Close
$12.85
Open
$12.89
Day's High
$12.93
Day's Low
$12.38
Volume
1,663,167
Avg. Vol
1,182,580
52-wk High
$15.95
52-wk Low
$8.95

Search Stocks

McCourt, Thomas 

Brief Biography

Mr. Thomas A. McCourt is Senior Vice President - Marketing and Sales, Chief Commercial Officer of Ironwood Pharmaceuticals, Inc., since September 2009. Prior to joining Ironwood, Mr. McCourt led the U.S. brand team for denosumab at Amgen Inc. from April 2008 to August 2009. Prior to that, Mr. McCourt was with Novartis AG from 2001 to 2008, where he directed the launch and growth of Zelnorm for the treatment of patients with IBS-C and CIC and held a number of senior commercial roles, including vice president of strategic marketing and operations. Mr. McCourt was also part of the founding team at Astra Merck Inc. Mr. McCourt has a degree in pharmacy from the University of Wisconsin.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
448,425 -- 682,895 1,131,320

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 40,000 468,000.00
Name Fiscal Year Total

Bryan Roberts

--

Peter Hecht

2,410,130

Michael Higgins

1,007,600

Thomas Graney

--

Mark Currie

1,702,650

Thomas McCourt

1,131,320
As Of 30 Dec 2013
Search Stocks